메뉴 건너뛰기




Volumn 113, Issue 1, 2009, Pages

Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients

Author keywords

Chronic kidney disease; Costs; Diabetes; Hyperparathyroidism

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CARDIOVASCULAR AGENT;

EID: 67649873051     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228076     Document Type: Article
Times cited : (42)

References (20)
  • 1
    • 32144450966 scopus 로고    scopus 로고
    • Facing the diabetes epidemic - Mandatory reporting of glycosylated hemoglobin values in New York City
    • Steinbrook R: Facing the diabetes epidemic - mandatory reporting of glycosylated hemoglobin values in New York City. N Engl J Med 2006;354:545-548.
    • (2006) N Engl J Med , vol.354 , pp. 545-548
    • Steinbrook, R.1
  • 2
    • 0003717478 scopus 로고    scopus 로고
    • (accessed January 2, 2008, last modified February 2, 2006)
    • Centers for Disease Control: National diabetes fact sheet, United States 2005. http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2005.pdf (accessed January 2, 2008, last modified February 2, 2006).
    • National Diabetes Fact Sheet, United States 2005
  • 3
    • 56349167188 scopus 로고    scopus 로고
    • accessed January 2, 2008, page last reviewed March 26, 2007
    • Centers for Disease Control: Diabetes data and trends. http://www.cdc.gov/diabetes/statistics/incidence/fig1.htm (accessed January 2, 2008, page last reviewed March 26, 2007).
    • Diabetes Data and Trends
  • 4
    • 14644395218 scopus 로고    scopus 로고
    • National Center for Health Statistics: US Department of Health and Human Services, (accessed January 2, 2008, page last updated December 31, 2007)
    • National Center for Health Statistics: Deaths - leading causes (2005). US Department of Health and Human Services, Centers for Disease Control. http://www.cdc.gov/nchs/fastats/lcod.htm (accessed January 2, 2008, page last updated December 31, 2007).
    • (2005) Deaths - Leading Causes
  • 5
    • 69349087242 scopus 로고    scopus 로고
    • accessed January 2, 2008
    • National Kidney Foundation: Diabetes and kidney disease. http://www.kidney.org/kidneydisease/diabetesckd/index.cfm (accessed January 2, 2008).
    • Diabetes and Kidney Disease
  • 6
    • 0037228105 scopus 로고    scopus 로고
    • Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
    • Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12. (Pubitemid 36043346)
    • (2003) American Journal of Kidney Diseases , vol.41 , Issue.1 , pp. 1-12
    • Coresh, J.1    Astor, B.C.2    Greene, T.3    Eknoyan, G.4    Levey, A.S.5
  • 11
    • 39749147588 scopus 로고    scopus 로고
    • Epidemiology and economic burden of brain metastases among patients with primary breast cancer: Results from a US claims data analysis
    • DOI 10.1007/s10549-007-9601-0
    • Pelletier EM, Shim B, Goodman S, Amonkar MM: Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis. Breast Cancer Res Treat 2008;108:297-305. (Pubitemid 351311367)
    • (2008) Breast Cancer Research and Treatment , vol.108 , Issue.2 , pp. 297-305
    • Pelletier, E.M.1    Shim, B.2    Goodman, S.3    Amonkar, M.M.4
  • 12
    • 33947598628 scopus 로고    scopus 로고
    • Reduced mortality rates after intensive statin therapy in managed-care patients
    • DOI 10.1111/j.1524-4733.2006.00163.x
    • Fintel D, Joyce A, Mackell J, Graff J, Kuntze E, Ollendorf DA: Reduced mortality rates after intensive statin therapy in managed-care patients. Value Health 2007;10:161-169. (Pubitemid 46481143)
    • (2007) Value in Health , vol.10 , Issue.2 , pp. 161-169
    • Fintel, D.1    Joyce, A.2    Mackell, J.3    Graff, J.4    Kuntze, E.5    Ollendorf, D.A.6
  • 13
    • 33845700085 scopus 로고    scopus 로고
    • Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
    • DOI 10.1038/sj.ki.5002009, PII 5002009
    • Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71:31-38. (Pubitemid 44967731)
    • (2007) Kidney International , vol.71 , Issue.1 , pp. 31-38
    • Levin, A.1    Bakris, G.L.2    Molitch, M.3    Smulders, M.4    Tian, J.5    Williams, L.A.6    Andress, D.L.7
  • 14
    • 2442587499 scopus 로고    scopus 로고
    • Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings
    • DOI 10.1093/ndt/gfh123
    • Dobrez DG, Mathes A, Amdahl M, Marx SE, Melnick JZ, Sprague SM: Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings. Nephrol Dial Transplant 2004;19:1174-1181. (Pubitemid 38628138)
    • (2004) Nephrology Dialysis Transplantation , vol.19 , Issue.5 , pp. 1174-1181
    • Dobrez, D.G.1    Mathes, A.2    Amdahl, M.3    Marx, S.E.4    Melnick, J.Z.5    Sprague, S.M.6
  • 15
    • 33750425045 scopus 로고    scopus 로고
    • Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis
    • DOI 10.2165/00044011-200626110-00002
    • Rosery H, Bergemann R, Marx SE, Boehnke A, Melnick J, Sterz R, Williams L: Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis. Clin Drug Invest 2006;26:629-638. (Pubitemid 44641875)
    • (2006) Clinical Drug Investigation , vol.26 , Issue.11 , pp. 629-638
    • Rosery, H.1    Bergemann, R.2    Marx, S.E.3    Boehnke, A.4    Melnick, J.5    Sterz, R.6    Williams, L.7
  • 16
    • 38149138055 scopus 로고    scopus 로고
    • Pharmacoeconomic analysis of paricalcitol and calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis: Impact of hospitalizations and survival
    • Schumock GT, Arruda JA, Marx SE, Melnick JZ, Sterz R, Williams LA: Pharmacoeconomic analysis of paricalcitol and calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis: impact of hospitalizations and survival. J Med Econ 2007;10:393-409.
    • (2007) J Med Econ , vol.10 , pp. 393-409
    • Schumock, G.T.1    Arruda, J.A.2    Marx, S.E.3    Melnick, J.Z.4    Sterz, R.5    Williams, L.A.6
  • 19
    • 44449113816 scopus 로고    scopus 로고
    • Vitamin D receptor activation and survival in chronic kidney disease
    • DOI 10.1038/ki.2008.35, PII KI200835
    • Kovesdy CP, Kalantar-Zadeh K: Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int 2008;73:1355-1363. (Pubitemid 351770491)
    • (2008) Kidney International , vol.73 , Issue.12 , pp. 1355-1363
    • Kovesdy, C.P.1    Kalantar-Zadeh, K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.